These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29439935)

  • 1. Successful subcutaneous desensitization in a patient with allergy to ixekizumab.
    Jimenez RB; Vera DG; Rivera-Díaz R; Cortijo-Cascajares S; Ballesteros RM; Pastor MDCD
    J Allergy Clin Immunol Pract; 2018; 6(5):1761-1762. PubMed ID: 29439935
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful adalimumab desensitization after generalized urticaria and rhinitis.
    Rodríguez-Jiménez B; Domínguez-Ortega J; González-Herrada C; Kindelan-Recarte C; Loribo-Bueno P; Garrido-Peño N
    J Investig Allergol Clin Immunol; 2009; 19(3):246-7. PubMed ID: 19610276
    [No Abstract]   [Full Text] [Related]  

  • 3. Safe and Successful Protocol for Desensitization to Abiraterone.
    Núñez Acevedo B; Rubio Pérez M; Padial Vilchez A; de la Morena Gallego JM; Barro Ordovás JP; Reche Frutos M; Valbuena Garrido T
    J Investig Allergol Clin Immunol; 2019 Oct; 29(5):386-387. PubMed ID: 31621631
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque Psoriasis.
    Zhu Y; Marini JC; Song M; Randazzo B; Shen YK; Li S; Zhou H
    J Invest Dermatol; 2019 Aug; 139(8):1830-1834.e6. PubMed ID: 30851300
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization.
    Arroabarren E; Aznal E; Anda M; Sanchez-Valverde F
    Pediatr Allergy Immunol; 2019 Jun; 30(4):491-494. PubMed ID: 30817035
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab：A case report.
    Gan H; Wang L; Fu W; Zhang J; Yu M; Liu G
    J Clin Pharm Ther; 2019 Jun; 44(3):486-488. PubMed ID: 30859588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized inflammatory reactions at sites of subcutaneous methotrexate injections during treatment with ultraviolet B.
    Muthiah S; Charlton F; Farr PM
    Br J Dermatol; 2018 Jul; 179(1):192-194. PubMed ID: 29341063
    [No Abstract]   [Full Text] [Related]  

  • 8. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.
    Mahdavinia M; Batra PS; Codispoti C
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):311-312. PubMed ID: 31247304
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful desensitization of three patients with hypersensitivity reactions to omalizumab.
    Owens G; Petrov A
    Curr Drug Saf; 2011 Nov; 6(5):339-42. PubMed ID: 22424542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.
    Cortellini G; Mascella F; Simoncelli M; Lippolis D; Focherini MC; Cortellini F; Cherubini C; Gavioli B; Ballardini G
    Pharmacology; 2018; 102(1-2):114-116. PubMed ID: 29953985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Subcutaneous Desensitization to Certolizumab Pegol.
    Peñalver MJ; Bautista-Villanueva S; Barranco R; Crespo JF; Mielgo R
    J Investig Allergol Clin Immunol; 2024 Jul; 34(4):272-274. PubMed ID: 38275251
    [No Abstract]   [Full Text] [Related]  

  • 12. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug allergy and Hymenoptera sensitivity.
    Luskin AT
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 2):1068-72. PubMed ID: 2600343
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful rapid oral clindamycin desensitization in a pediatric patient.
    Esty B; Minnicozzi S; Chu EC; Broyles AD; Yee CSK
    J Allergy Clin Immunol Pract; 2018; 6(6):2141-2142. PubMed ID: 29655773
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts in allergy: drug reactions.
    Evans R; Kim K; Mahr TA
    Curr Probl Pediatr; 1991; 21(5):185-92. PubMed ID: 2065523
    [No Abstract]   [Full Text] [Related]  

  • 17. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.
    Scherer K; Brockow K; Aberer W; Gooi JH; Demoly P; Romano A; Schnyder B; Whitaker P; Cernadas JS; Bircher AJ;
    Allergy; 2013 Jul; 68(7):844-52. PubMed ID: 23745779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful rapid push subcutaneous desensitization in a patient with delayed local hypersensitivity reactions to immunoglobulins.
    Ghurye RR; Bright P; Lowe D; Buckland MS
    J Allergy Clin Immunol Pract; 2019; 7(8):2906-2908. PubMed ID: 31102702
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.